Welcome!

News Feed Item

Spastic Cerebral Palsy Global Clinical Trials Review, H2, 2014

LONDON, Aug. 11, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

Spastic Cerebral Palsy Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/2280941/Spastic-Cerebral-Palsy-Global-Clinical-Trials-Review-H2-2014.html

Spastic Cerebral Palsy Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Spastic Cerebral Palsy Global Clinical Trials Review, H2, 2014" provides data on the Spastic Cerebral Palsy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Spastic Cerebral Palsy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Spastic Cerebral Palsy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Spastic Cerebral Palsy 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Spastic Cerebral Palsy to Central Nervous System Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Spastic Cerebral Palsy to Central Nervous System Clinical Trials 17
Clinical Trials in E7 Countries by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Unaccomplished Trials of Spastic Cerebral Palsy 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Spastic Cerebral Palsy Therapeutics Clinical Trials 27
Prominent Drugs 28
Clinical Trial Profiles 29
Clinical Trial Overview of Top Companies 29
Medy-Tox Inc. 29
Clinical Trial Overview of Medy-Tox Inc. 29
GlaxoSmithKline plc 30
Clinical Trial Overview of GlaxoSmithKline plc 30
Daiichi Sankyo Company, Limited 31
Clinical Trial Overview of Daiichi Sankyo Company, Limited 31
Clinical Trial Overview of Top Institutes / Government 32
All India Institute of Medical Sciences 32
Clinical Trial Overview of All India Institute of Medical Sciences 32
Gujarat Ayurved University 33
Clinical Trial Overview of Gujarat Ayurved University 33
Azienda Ospedaliera Istituti Clinici Di Perfezionamento 34
Clinical Trial Overview of Azienda Ospedaliera Istituti Clinici Di Perfezionamento 34
Duke University Medical Center 35
Clinical Trial Overview of Duke University Medical Center 35
Wright State University 36
Clinical Trial Overview of Wright State University 36
ALYN Pediatric and Adolescent Rehabilitation Center 37
Clinical Trial Overview of ALYN Pediatric and Adolescent Rehabilitation Center 37
Erasmus MC 38
Clinical Trial Overview of Erasmus MC 38
Chang Gung Memorial Foundation 39
Clinical Trial Overview of Chang Gung Memorial Foundation 39
National Center for Complementary and Alternative Medicine 40
Clinical Trial Overview of National Center for Complementary and Alternative Medicine 40
Stanford University 41
Clinical Trial Overview of Stanford University 41
Five Key Clinical Profiles 42
Appendix 57
Abbreviations 57
Definitions 57
Research Methodology 58
Secondary Research 58
About GlobalData 59
Contact Us 59
Disclaimer 59
Source 59

List of Tables

Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials by Region, 2014* 7
Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Spastic Cerebral Palsy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Spastic Cerebral Palsy Therapeutics Clinical Trials, Europe, Top Countries, 2014* 11
Spastic Cerebral Palsy Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Spastic Cerebral Palsy Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Proportion of Spastic Cerebral Palsy to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 14
Spastic Cerebral Palsy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Spastic Cerebral Palsy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Spastic Cerebral Palsy to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 17
Spastic Cerebral Palsy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 18
Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials by Phase, 2014* 19
Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 20
Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, by End Point Status, 2014* 22
Spastic Cerebral Palsy Therapeutics, Global, Terminated Clinical Trials, 2014* 23
Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 24
Spastic Cerebral Palsy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 25
Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 26
Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 27
Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 28
Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Medy-Tox Inc., 2014* 29
Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 30
Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2014* 31
Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by All India Institute of Medical Sciences, 2014* 32
Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Gujarat Ayurved University, 2014* 33
Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Ospedaliera Istituti Clinici Di Perfezionamento, 2014* 34
Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University Medical Center, 2014* 35
Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Wright State University, 2014* 36
Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by ALYN Pediatric and Adolescent Rehabilitation Center, 2014* 37
Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2014* 38
Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Chang Gung Memorial Foundation, 2014* 39
Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Complementary and Alternative Medicine, 2014* 40
Spastic Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2014* 41

List of Figures

Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Spastic Cerebral Palsy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Spastic Cerebral Palsy Therapeutics Clinical Trials, Europe, Top Countries (%), 2014* 11
Proportion of Spastic Cerebral Palsy to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 14
Spastic Cerebral Palsy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Spastic Cerebral Palsy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Spastic Cerebral Palsy to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 17
Spastic Cerebral Palsy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 18
Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials by Phase (%), 2014* 19
Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 20
Spastic Cerebral Palsy Therapeutics, Global, Clinical Trials by Trial Status, 2014* 21
Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 24
Spastic Cerebral Palsy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 25
Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 26
Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 27
Spastic Cerebral Palsy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 28
GlobalData Methodology 58


Read the full report:
Spastic Cerebral Palsy Global Clinical Trials Review, H2, 2014

https://www.reportbuyer.com/product/2280941/Spastic-Cerebral-Palsy-Global-Clinical-Trials-Review-H2-2014.html

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

 

SOURCE ReportBuyer

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
SYS-CON Events announced today that Juniper Networks (NYSE: JNPR), an industry leader in automated, scalable and secure networks, will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Juniper Networks challenges the status quo with products, solutions and services that transform the economics of networking. The company co-innovates with customers and partners to deliver automated, scalable and secure network...
Cognitive Computing is becoming the foundation for a new generation of solutions that have the potential to transform business. Unlike traditional approaches to building solutions, a cognitive computing approach allows the data to help determine the way applications are designed. This contrasts with conventional software development that begins with defining logic based on the current way a business operates. In her session at 18th Cloud Expo, Judith S. Hurwitz, President and CEO of Hurwitz & ...
Everyone wants to use containers, but monitoring containers is hard. New ephemeral architecture introduces new challenges in how monitoring tools need to monitor and visualize containers, so your team can make sense of everything. In his session at @DevOpsSummit, David Gildeh, co-founder and CEO of Outlyer, will go through the challenges and show there is light at the end of the tunnel if you use the right tools and understand what you need to be monitoring to successfully use containers in your...
The explosion of new web/cloud/IoT-based applications and the data they generate are transforming our world right before our eyes. In this rush to adopt these new technologies, organizations are often ignoring fundamental questions concerning who owns the data and failing to ask for permission to conduct invasive surveillance of their customers. Organizations that are not transparent about how their systems gather data telemetry without offering shared data ownership risk product rejection, regu...
@GonzalezCarmen has been ranked the Number One Influencer and @ThingsExpo has been named the Number One Brand in the “M2M 2016: Top 100 Influencers and Brands” by Analytic. Onalytica analyzed tweets over the last 6 months mentioning the keywords M2M OR “Machine to Machine.” They then identified the top 100 most influential brands and individuals leading the discussion on Twitter.
Grape Up is a software company, specialized in cloud native application development and professional services related to Cloud Foundry PaaS. With five expert teams that operate in various sectors of the market across the USA and Europe, we work with a variety of customers from emerging startups to Fortune 1000 companies.
Financial Technology has become a topic of intense interest throughout the cloud developer and enterprise IT communities. Accordingly, attendees at the upcoming 20th Cloud Expo at the Javits Center in New York, June 6-8, 2017, will find fresh new content in a new track called FinTech.
New competitors, disruptive technologies, and growing expectations are pushing every business to both adopt and deliver new digital services. This ‘Digital Transformation’ demands rapid delivery and continuous iteration of new competitive services via multiple channels, which in turn demands new service delivery techniques – including DevOps. In this power panel at @DevOpsSummit 20th Cloud Expo, moderated by DevOps Conference Co-Chair Andi Mann, panelists will examine how DevOps helps to meet th...
With major technology companies and startups seriously embracing Cloud strategies, now is the perfect time to attend @CloudExpo | @ThingsExpo, June 6-8, 2017, at the Javits Center in New York City, NY and October 31 - November 2, 2017, Santa Clara Convention Center, CA. Learn what is going on, contribute to the discussions, and ensure that your enterprise is on the right path to Digital Transformation.
SYS-CON Events announced today that Hitachi, the leading provider the Internet of Things and Digital Transformation, will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Hitachi Data Systems, a wholly owned subsidiary of Hitachi, Ltd., offers an integrated portfolio of services and solutions that enable digital transformation through enhanced data management, governance, mobility and analytics. We help globa...
SYS-CON Events announced today that Interoute, owner-operator of one of Europe's largest networks and a global cloud services platform, has been named “Bronze Sponsor” of SYS-CON's 20th Cloud Expo, which will take place on June 6-8, 2017 at the Javits Center in New York, New York. Interoute is the owner-operator of one of Europe's largest networks and a global cloud services platform which encompasses 12 data centers, 14 virtual data centers and 31 colocation centers, with connections to 195 add...
@DevOpsSummit at Cloud taking place June 6-8, 2017, at Javits Center, New York City, is co-located with the 20th International Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The widespread success of cloud computing is driving the DevOps revolution in enterprise IT. Now as never before, development teams must communicate and collaborate in a dynamic, 24/7/365 environment. There is no time to wait for long developm...
The age of Digital Disruption is evolving into the next era – Digital Cohesion, an age in which applications securely self-assemble and deliver predictive services that continuously adapt to user behavior. Information from devices, sensors and applications around us will drive services seamlessly across mobile and fixed devices/infrastructure. This evolution is happening now in software defined services and secure networking. Four key drivers – Performance, Economics, Interoperability and Trust ...
Blockchain is a shared, secure record of exchange that establishes trust, accountability and transparency across supply chain networks. Supported by the Linux Foundation's open source, open-standards based Hyperledger Project, Blockchain has the potential to improve regulatory compliance, reduce cost and time for product recall as well as advance trade. Are you curious about Blockchain and how it can provide you with new opportunities for innovation and growth? In her session at 20th Cloud Exp...
Five years ago development was seen as a dead-end career, now it’s anything but – with an explosion in mobile and IoT initiatives increasing the demand for skilled engineers. But apart from having a ready supply of great coders, what constitutes true ‘DevOps Royalty’? It’ll be the ability to craft resilient architectures, supportability, security everywhere across the software lifecycle. In his keynote at @DevOpsSummit at 20th Cloud Expo, Jeffrey Scheaffer, GM and SVP, Continuous Delivery Busin...